Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP2J2 |
| Upstream (Parents) |
|---|
| (<<) HRSP12 → CYP2J2 |
| (<<) SLC27A2 → CYP2J2 |
| (<<) BDH1 → CYP2J2 |
| Downstream (Children) |
|---|
| CYP2J2 → NR3C2 (>>) |
| CYP2J2 → CDKN1C (>>) |
| CYP2J2 → IL17RB (>>) |
| CYP2J2 → C4orf19 (>>) |
| CYP2J2 → HMGCS2 (>>) |
| CYP2J2 → HPGD (>>) |
| CYP2J2 → UNC93A (>>) |
| CYP2J2 → XYLB (>>) |
| CYP2J2 → EGFR (>>) |
| CYP2J2 → IFNA8 (>>) |
| CYP2J2 → RAB26 (>>) |
| CYP2J2 → PLA2G1B (>>) |
| CYP2J2 → SUCLG2 (>>) |
| CYP2J2 → MAOA (>>) |
| CYP2J2 → KREMEN2 (>>) |
| CYP2J2 → EFNB2 (>>) |
| CYP2J2 → VIPR1 (>>) |
| CYP2J2 → TTTY1B///TTTY1 (>>) |
